Search

Search Constraints

You searched for: Author/Creator Spitaleri, Daniele

Search Results

1. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. (5th September 2017)

3. Comparative effectiveness in multiple sclerosis: A methodological comparison. (March 2023)

4. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis. (August 2015)

5. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Issue 4 (13th January 2019)

6. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

7. Contribution of different relapse phenotypes to disability in multiple sclerosis. (February 2017)

8. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]. (January 2022)

9. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis. (June 2023)

10. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. (2nd February 2021)